Company: COHN
Filing Date: 2025-03-12
Form Type: 10-K
Source: 0001437749-25-007158
Chunk: 3034

Company: Cohen & Co Inc.
Filing Date: 2025-03-12
Form: 10-K
Item: Item 7
Chunk 3034
---
 in the future, a significant deferred tax benefit or deferred tax expense would be recognized as a component of earnings.
   ﻿ 
   The Company’s policy is to record penalties and interest as a component of income tax expense (benefit) in the consolidated statements of operations. 
   ﻿ 
   T. Other Comprehensive Income / (Loss) 
   ﻿ 
   The Company reports the components of comprehensive income / (loss) within the consolidated statements of operations and comprehensive income / (loss). Comprehensive income / (loss) includes net income / (loss) from foreign translation adjustment.
   ﻿ 
   U. Earnings / (Loss) Per Common Share 
   ﻿ 
   In accordance with FASB ASC 260, Earnings Per Share (“ASC 260”), the Company presents both basic and diluted earnings / (loss) per common share in its consolidated financial statements and footnotes. Basic earnings / (loss) per common share (“Basic EPS”) excludes dilution and is computed by dividing net income or loss allocable to common stockholders or members by the weighted average number of common shares and restricted stock entitled to non-forfeitable dividends outstanding for the period. Diluted earnings per common share (“Diluted EPS”) reflects the potential dilution of common stock equivalents (such as restricted stock and restricted units entitled to forfeitable dividends, in-the-money stock options, and convertible debt, if they are not anti-dilutive). See note 26 for the computation of earnings/(loss) per common share.
   ﻿ 
   V. Business Concentration 
   ﻿ 
   A significant portion of the Company’s asset management revenues in a year  may be derived from a small number of transactions. For the year ended  December 31, 2024, the Company earned asset management revenue from CDOs of $1,566 and $7,443 from other investment funds. 
    
   Other than revenue earned in its gestation repo operations, the Company’s trading revenue is generated from transactions with a diverse set of institutional customers.  The Company does not consider its trading revenue, other than revenue earned in its gestation repo operations, to be concentrated from a customer or counterparty perspective. See note 11 for discussion of concentrations within the gestation repo operations.
   ﻿ 

        F-
       16

   W.  Fair Value of Financial Instruments 
   ﻿ 
   The following methods and assumptions were used by the Company in estimating the fair value of its financial instruments.